NSPR InspireMD, Inc.
Healthcare$0.95-5.00%ClosedMarket Cap: $44.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.68
P/S
4.32
EV/EBITDA
-0.73
DCF Value
$-4.76
FCF Yield
-85.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
28.1%
Operating Margin
-480.6%
Net Margin
-344.1%
ROE
-81.5%
ROA
-66.1%
ROIC
-110.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $3.4M | 20.2% | $-14.0M | $289.0K | $— | — |
| Q4 null | $3.1M | 37.5% | $-12.1M | $-11.8M | $— | — |
| FY null | $9.0M | 29.5% | $-49.1M | $-48.8M | $— | — |
| Q3 null | $2.5M | 34.2% | $-13.1M | $-12.7M | $— | — |
| Q2 null | $1.8M | 17.6% | $-13.0M | $-13.2M | $— | — |
| Q1 null | $1.5M | 19.1% | $-11.5M | $-11.2M | $— | — |
| Q4 null | $1.9M | 24.1% | $-9.4M | $-9.2M | $— | — |
| FY null | $7.0M | 21.5% | $-33.5M | $-32.0M | $— | — |
| Q3 null | $1.8M | 22.9% | $-8.5M | $-7.9M | $— | — |
| Q2 null | $1.7M | 19.0% | $-8.3M | $-7.9M | $— | — |
| Q1 null | $1.5M | 19.3% | $-7.4M | $-7.0M | $— | — |
| Q4 2023 | $1.8M | 28.7% | $-5.8M | $-5.4M | $-0.25 | — |